This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Iqvia Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Charalampos Tsirmpas: Inventor of a Psychiatric Risk Prediction Method.
Introduction
Charalampos Tsirmpas is an inventor based in San Francisco, California. His patent work includes a method designed to predict the risk of onset or relapse of a psychiatric condition by combining speech, biosignals, and clinical assessments.
Latest Patents
Tsirmpas is associated with 1 patent, titled “Method for Predicting Risk of Relapse or Onset of a Psychiatric Condition.” The method records a user reciting an emotionally evocative story while concurrently capturing biosignals. It identifies psychophysiological markers that correlate with emotional responses and biosignals, then relates those markers to clinical assessments to build a predictive model. The model can analyze another user’s biosignals, estimate the risk of a condition’s onset, and trigger a notification when that risk exceeds a specified threshold.
Career Highlights
Tsirmpas is associated with IQVIA Inc. His patent reflects an approach to psychiatric risk assessment that combines behavioral and physiological data with clinical information.
Collaborations
His listed coworkers include Georgios Eleftheriou and Panagiotis Fatouros. Their names are associated with his professional context, though the supplied information does not specify their roles in the patent.
Conclusion
Charalampos Tsirmpas’s patent describes a data-driven method for assessing psychiatric risk through the integration of speech, biosignals, and clinical assessments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile